Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.8B | 2.8B | 2.8B | 2.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 308M | 443M | 341M | 343M |
Other operating expenses | 188M | 125M | 35M | 131M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 1.0B | 1.4B | 1.3B |
Tax provision | 242M | 235M | 286M | 275M |
Net income | 940M | 776M | 1.1B | 1.0B |
Basic EPS | — | 1.6 | 2.3 | 2.1 |
Diluted EPS | — | 1.6 | 2.3 | 2.1 |
Basic average shares | — | 388.1M | 391.0M | 398.5M |
Diluted average shares | — | 388.1M | 391.0M | 398.5M |
EBITDA | — | — | — | — |
Net income from continuing op. | 940M | 776M | 1.1B | 1.0B |
Minority interests | -197M | -166M | -222M | -187M |
Preferred stock dividends | — | — | — | — |